Metabolon Develops Software Method to Automate the Organization of LC/MS and GC/MS Libraries
RESEARCH TRIANGLE PARK, N.C. (October 19, 2010)—Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announces the online publication of “Organization of GC/MS and LC/MS Metabolomics Data into Chemical Libraries” in the Journal of Cheminformatics. The article describes the automated identification of individual compounds based on the biological variability in compound concentrations across multiple samples. A US patent, US7,561,975, has been issued to Metabolon on the methodology described in the paper.
To access the article please click here.
About Metabolon
Metabolon is a diagnostics and services company offering the industry’s leading biochemical profiling platform. Metabolon’s patented platform provides a global analysis of complex biological samples for the discovery of markers and pathways associated with drug action and disease. This metabolomics-driven approach enables the identification of biomarkers useful for the development of a wide range of diagnostics and provides insight into complex biochemical processes such as drug action, toxicology and bioprocess optimization. For more information about Metabolon, please visit www.metabolon.com
